SANDRINE MOTOKWA NTSANG: Open Payments
NPI 1023710704 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,081 in 87 payments from 13 companies in 2025. Trend: 2023 $2,459 · 2024 $3,615 · 2025 $2,081
Food & beverage: $2,072Education: $10
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 18 | $593 |
| ABBVIE INC. | 26 | $430 |
| Axsome Therapeutics, Inc. | 9 | $218 |
| Alkermes, Inc. | 7 | $189 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $160 |
| E.R. Squibb & Sons, L.L.C. | 3 | $146 |
| Lundbeck LLC | 4 | $82 |
| Vanda Pharmaceuticals Inc. | 3 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $57 |
| Almatica Pharma LLC | 3 | $55 |
Products named: REXULTI, VRAYLAR, Auvelity, CAPLYTA, LYBALVI, COBENFY, FANAPT, TRINTELLIX.
Industry payments across TX — which companies pay providers there.
